These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3527839

  • 1. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A, Kobayashi T, Nihei J.
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [Abstract] [Full Text] [Related]

  • 2. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A, Ohneda M.
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [Abstract] [Full Text] [Related]

  • 3. Insulinotropic action of human glicentin in dogs.
    Ohneda A, Ohneda K, Nagasaki T, Sasaki K.
    Metabolism; 1995 Jan; 44(1):47-51. PubMed ID: 7854165
    [Abstract] [Full Text] [Related]

  • 4. Effect of intraluminal administration of amino acids upon plasma glicentin.
    Ohneda A, Kobayashi T, Nihei J, Takahashi H.
    Diabetes Res Clin Pract; 1988 Oct 14; 5(4):265-70. PubMed ID: 3069408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
    Moody AJ, Holst JJ, Thim L, Jensen SL.
    Nature; 1981 Feb 05; 289(5797):514-6. PubMed ID: 7007887
    [Abstract] [Full Text] [Related]

  • 9. Effect of C-terminal fragments of glucagon on insulin secretion in dogs.
    Ohneda A, Ohneda K.
    Metabolism; 1994 Jun 05; 43(6):771-5. PubMed ID: 8201969
    [Abstract] [Full Text] [Related]

  • 10. Insulin releasing action of N-terminal peptides of glucagon in dogs.
    Ohneda A, Ohneda K, Koizumi F.
    Tohoku J Exp Med; 1992 Aug 05; 167(4):287-95. PubMed ID: 1488751
    [Abstract] [Full Text] [Related]

  • 11. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA, Uttenthal LO, Bryant MG, Christofides ND, Moody AJ, Bloom SR.
    Endocrinology; 1983 Mar 05; 112(3):917-23. PubMed ID: 6822217
    [Abstract] [Full Text] [Related]

  • 12. The primary structure of porcine glicentin (proglucagon).
    Thim L, Moody AJ.
    Regul Pept; 1981 May 05; 2(2):139-50. PubMed ID: 6894800
    [Abstract] [Full Text] [Related]

  • 13. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
    Anini Y, Jarrousse C, Chariot J, Nagain C, Yanaihara N, Sasaki K, Bernad N, Le Nguyen D, Bataille D, Rozé C.
    Pancreas; 2000 May 05; 20(4):348-60. PubMed ID: 10824688
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence for transformation of glucagon-like immunoreactivity of gut into pancreatic glucagon in vivo.
    Korányi L, Péterfy F, Szabó J, Török A, Guóth M, Tamás G.
    Diabetes; 1981 Sep 05; 30(9):792-4. PubMed ID: 6114889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P, Kervran A, Martinez J, Bataille D.
    Anal Biochem; 1988 Aug 15; 173(1):151-9. PubMed ID: 3189794
    [Abstract] [Full Text] [Related]

  • 20. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
    Rodier G, Magous R, Mochizuki T, Martinez J, Nguyen DL, Bali JP, Bataille D, Jarrousse C.
    Pflugers Arch; 1997 Nov 15; 434(6):729-34. PubMed ID: 9306005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.